|Therapeutic Class:||Aldose reductase inhibitor|
|Manufacturer:||Eskayef Bangladesh Ltd.|
|Last Updated:||2020-11-21 18:15:00|
Aldorin Tablet contains Epalrestat. Aldorin uses:
Aldorin Tablet contains Epalrestat 50 mg. Aldorin doses:
In general, for adults, take 1 tablet (50 mg of the active ingredient) at a time, three times daily, before meal. The dosage may be adjusted according to the age or symptoms.
The most commonly reported adverse reactions include abdominal pain, nausea, rash, itch, erythema and blister.
Epalrestat is aldose reductase inhibitor. The aldose reductase inhibitors have a distinct mechanism of action, affecting the underlying disease process in diabetic neuropathy, although the extent of the polyol pathway involvement is yet to be determined. Epalrestat reduces sorbitol accumulation in the sciatic nerve, erythrocytes. Epalrestat may improve motor and sensory nerve conduction velocity and subjective neuropathy symptoms.
Urine may turn yellowish brown or reddish after taking the medicine, because the yellowish brown or reddish color is attributed to components of this medicine.
There are no known drug interactions and none well documented.
Pregnancy Category- Not Classified. FDA has not yet classified the drug into a specified pregnancy category
Hypersensitivity. Pregnant or breastfeeding.
Aldorin Tablet price in Bangladesh 11.20